trial · 2023

The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol

McMaster University

Unreviewed source record: Inclusion in the index is not an endorsement of the methods, findings, or clinical relevance. This page is excluded from search indexing until editorial review.

Study designClinical trial

Evidence classcontrolled-trial

Open accessReported open

CitationsNot available

Abstract

POT-GFR-PK is a single dose pharmacokinetic study oral tetrahydrocannabinol (THC) and cannabidiol (CBD) in healthy adult controls and individuals with chronic kidney disease including those treated with in-center hemodialysis.

Topics and compounds

CBDTHCCannabisChronic Kidney DiseasesDialysis

Continue with the source

Open original record ↗